ID   GM01503
AC   CVCL_8A59
SY   GM-1503; GM1503; GM01503A
DR   CLO; CLO_0031444
DR   BioSample; SAMN00806882
DR   Coriell; GM01503
DR   Wikidata; Q54836876
RX   PubMed=2376596;
RX   PubMed=30471880;
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y6M
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
RX   PubMed=2376596; DOI=10.1016/S0021-9258(19)38301-2;
RA   Huh T.-L., Casazza J.P., Huh J.-W., Chi Y.-T., Song B.J.;
RT   "Characterization of two cDNA clones for pyruvate dehydrogenase E1
RT   beta subunit and its regulation in tricarboxylic acid cycle-deficient
RT   fibroblast.";
RL   J. Biol. Chem. 265:13320-13326(1990).
//
RX   PubMed=30471880; DOI=10.1016/j.kint.2018.08.038; PMCID=PMC6389356;
RA   Johnson S.C., Martinez F., Bitto A., Gonzalez B., Tazaerslan C.,
RA   Cohen C., Delaval L., Timsit J., Knebelmann B., Terzi F., Mahal T.,
RA   Zhu Y.-Z., Morgan P.G., Sedensky M.M., Kaeberlein M., Legendre C.,
RA   Suh Y., Canaud G.;
RT   "mTOR inhibitors may benefit kidney transplant recipients with
RT   mitochondrial diseases.";
RL   Kidney Int. 95:455-466(2019).
//